During the Fortune Brainstorm Health conference on Wednesday, Eric Lefkofsky, co-founder and CEO of Tempus, stated “Gathering molecular data is one thing, but you also need clinical data. You need therapeutic and outcome response data.” This is what Tempus is all about.Lefkofsky was motivated to start Tempus during his wife’s treatment for breast cancer. He believing that pertinent data about how a specific treatment performs, in varying groups of patients, was not available to oncologists. Tempus seeks to fine tune cancer treatment by combining genomic information along with therapeutic data. In addition to information about a patient’s DNA and RNA makeup, clinicians need to know how they are responding to whichever treatment they are on. Lefkofsky states “That’s the sort of data that should flow freely between researchers, clinicians, and others.”
In order to achieve that goal, Tempus has developed an operating system to battle cancer by a layer of technology over existing electronic medical record and pathology systems to gather data, scrub it, and return the clean version to each original source to validate and verify. This type of data can then be used to discover patterns between treatments and results.Born in Southfield, Michigan in 1969, Eric Lefkofsky is an American entrepreneur. He received his Juris Doctor from the University of Michigan Law School, after graduating from University of Michigan with honors. Among his many business achievements, Lefksofky co-founded, and currently Chairs, Groupon, a global e-commerce site.
Along with his wife, Elizabeth, he began the Lefkofsky Family Foundation in 2006. The charitable foundation is private, focusing on children, and seeks to put forth high-impact initiatives to improve lives in the communities served. In 2013, they joined The Giving Pledge, the goal of which is to inspire the wealthy to give half of their net worth to philanthropy.Eric Lefkofsky is an adjunct professor at the University of Chicago and serves as a Trustee of The Art Institute of Chicago, and Lurie Children’s Hospital of Chicago. He is Chairman of the Board of Trustees of Chicago’s Steppenwolf Theatre Company and authored Accelerated Disruption.